Compliance-57 (4): Prior intimation to the beginning of the quarter
Filed with BSE · · 1 page · English
Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Statement Of Deviation & Variation
- Compliance-57 (5): intimation after the end of quarter
- Transgene Biotek Limited. Press Release Jul 13 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Jun 20 2026
Later from Transgene Biotek
- Transgene Biotek Limited. Press Release Jul 23 2026
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07, 2026.
- 1)The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026.2) The Board Considered And Approved The Limited Review Report (Standalone & Consolidated) Of The Comp
- Transgene Biotek Limited. Press Release Aug 07 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek